# Emergent BioSolutions Inc.: Form 8-K, filed Dec 6, 2022

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2022-12-06
- Accepted by EDGAR: Dec 6, 2022, 07:01 ET
- Period: 2022-12-06
- Accession: 0001367644-22-000152
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000136764422000152/ebs-20221206.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000136764422000152/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000136764422000152/ebs-20221206.htm

Filed Dec 6, 2022.
Source: SEC EDGAR, the filing index for accession 0001367644-22-000152. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.
